We would like to thank each of our sponsors for their generous support - as without them this event would not be possible.
For more information on the sponsor opportunities available, contact Anna Yeardley on +44 (0)1372 414222 or email firstname.lastname@example.org
Benchmark Research is a fully integrated network of sites with broad therapeutic experience and geographic reach. Standardized recruitment, retention, quality, training and site operations combined with Benchmark's “One Voice” model offer unmatched efficiencies. In 2016, we opened our first three Urgent & Family Care centers, which allows us to take on a wider variety of trials. Contact us today about making Benchmark Research sites the cornerstone of your next program.
PRA Health Sciences is a full service global contract research organization, providing specialized expertise across all phases and therapeutic areas of clinical development. We offer a broad spectrum of service models and solutions to pharmaceutical and biotechnology companies around the world - including but not limited to data management, statistical analysis, clinical trial management, and regulatory and drug development consulting.
Our global operations span more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia, and the Middle East, and more than 16,400 employees worldwide. Since 2000, we have participated in more than 3,800 clinical trials worldwide, assisting in the pivotal or supportive trials that led to more than 85 products receiving U.S. Food and Drug Administration or international regulatory approval. To learn more about PRA, please visit [www.prahs.com].
Covance Inc., the drug development business of Laboratory Corporation of America Holdings (LabCorp) headquartered in Princeton, New Jersey, USA, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®.
Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, helps our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions. Information on Covance’s solutions can be obtained through its website at www.covance.com.
ICON plc is a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 90 locations in 37 countries and has approximately 14,000 employees. Further information is available at www.iconplc.com.
PMG Research, Inc. is an integrated network of clinical research facilities in the United States. PMG has been conducting clinical trials since 1979. Their progressive organization is comprised of a team of highly effective professionals and a network of specially-designed sites. The goal is to provide exceptional services to sponsors and participants.
PMG has conducted over 8,100 research studies for hundreds of pharmaceutical sponsors and CROs. For more information, visit https://www.pmg-research.com/